An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
There is an urgent need for potent inhibitors of dengue virus (DENV) replication for the treatment and/or prophylaxis of infections with this virus. We here report on an aglycon analogue of the antibiotic teicoplanin (code name LCTA-949) that inhibits DENV-induced cytopathic effect (CPE) in a dose-d...
Main Authors: | Tine De Burghgraeve, Suzanne J F Kaptein, Nilda V Ayala-Nunez, Juan A Mondotte, Boris Pastorino, Svetlana S Printsevskaya, Xavier de Lamballerie, Michael Jacobs, Maria Preobrazhenskaya, Andrea V Gamarnik, Jolanda M Smit, Johan Neyts |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3356272?pdf=render |
Similar Items
-
Flavivirus Cell Entry and Membrane Fusion
by: Izabela Rodenhuis-Zybert, et al.
Published: (2011-02-01) -
Flavivirus Entry Receptors: An Update
by: Manuel Perera-Lecoin, et al.
Published: (2013-12-01) -
Flavivirus Receptors: Diversity, Identity, and Cell Entry
by: Mathilde Laureti, et al.
Published: (2018-09-01) -
Characterization of hepatocyte cell entry factors which govern flavivirus entry
by: Hu, Alexander H.
Published: (2021) -
Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells.
by: Marijke M F Alen, et al.
Published: (2011-01-01)